These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2221602)

  • 1. Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis.
    Brown MA; Scuderi P; McIntosh JC; Pfeffer K; Parsons P
    Am Rev Respir Dis; 1990 Oct; 142(4):984-5. PubMed ID: 2221602
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis.
    Suter S; Schaad UB; Roux-Lombard P; Girardin E; Grau G; Dayer JM
    Am Rev Respir Dis; 1989 Dec; 140(6):1640-4. PubMed ID: 2604293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
    Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
    Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of granulocyte elastase-alpha-proteinase inhibitor complex in patients with rheumatoid arthritis: measurements with a system free from rheumatoid factor interference.
    Fujimori J; Yoshino S; Hirata I
    J Rheumatol; 1996 Mar; 23(3):571. PubMed ID: 8833009
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serine protease inhibitors (serpins); regulators of coagulation and inflammation reactions with therapeutic potential].
    Hack CE; Abbink JJ; Nuijens JH
    Ned Tijdschr Geneeskd; 1990 May; 134(21):1035-9. PubMed ID: 2195358
    [No Abstract]   [Full Text] [Related]  

  • 6. [Elastase-alpha 1-proteinase inhibitor complex (E alpha 1 PI) and lactoferrin plasma concentrations in viral and bacterial infections].
    Tegtmeyer FK; Maacks S; van Wees J; Wood WG
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):96-101. PubMed ID: 2038354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An alpha 1-antitrypsin aerosol in the treatment of cystic fibrosis].
    Ferrer Calvete J; Aznar Lucea J; Morales Marín P; Pereda Pérez A; Llopis Carles R; Ribes Koninckx C; Ferrer González P; Marco Martínez V
    An Esp Pediatr; 1996 Feb; 44(2):109-11. PubMed ID: 8830566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immunoreactive interleukin-6 in cystic fibrosis.
    Nixon LS; Yung B; Bell SC; Elborn JS; Shale DJ
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1764-9. PubMed ID: 9620903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elastase, elastase inhibitors and chronic obstructive lung diseases].
    Kramps JA; Dijkman JH
    Ned Tijdschr Geneeskd; 1990 Jun; 134(23):1127-30. PubMed ID: 2192289
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alpha 1-antitrypsin (alpha 1-AT) in cystic fibrosis].
    Antonelli M; Castello MA; Borsetto Menghi AM
    Pediatria (Napoli); 1976 Jun; 84(2):203-7. PubMed ID: 1087973
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
    Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
    Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alpha-1-antitrypsin and cystic fibrosis (author's transl)].
    Pecau Y; Feigelson J; Feingold J
    Sem Hop; 1981 Sep 8-15; 57(29-32):1306-9. PubMed ID: 6269206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of proteinase inhibitors in human serum].
    Bondarenko AN
    Klin Lab Diagn; 2004 May; (5):11-5. PubMed ID: 15230109
    [No Abstract]   [Full Text] [Related]  

  • 14. Neonatal plasma concentrations of secretory leucocyte protease inhibitor.
    Sveger T; Ohlsson K; Svenningsen N
    Acta Paediatr; 1992 Mar; 81(3):270-1. PubMed ID: 1380860
    [No Abstract]   [Full Text] [Related]  

  • 15. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
    Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
    Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients.
    Griese M; Latzin P; Kappler M; Weckerle K; Heinzlmaier T; Bernhardt T; Hartl D
    Eur Respir J; 2007 Feb; 29(2):240-50. PubMed ID: 17050563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma tumour necrosis factor alpha in cystic fibrosis.
    Norman D; Elborn JS; Cordon SM; Rayner RJ; Wiseman MS; Hiller EJ; Shale DJ
    Thorax; 1991 Feb; 46(2):91-5. PubMed ID: 2014508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting alpha1-antitrypsin therapy in cystic fibrosis: can it still offer promise?
    Brennan S
    Eur Respir J; 2007 Feb; 29(2):229-30. PubMed ID: 17264320
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteolytic inactivation of alpha 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis.
    Suter S; Chevallier I
    Eur Respir J; 1991 Jan; 4(1):40-9. PubMed ID: 2026237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma serine protease inhibitors in dialyzed patients with chronic renal insufficiency].
    Kotschy M; Kassian J; Lampka M; Rajewski W
    Pol Merkur Lekarski; 1997 Feb; 2(8):93-5. PubMed ID: 9538647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.